Annual Cash & Cash Equivalents
$133.52 M
-$43.25 M-24.47%
31 December 2023
Summary:
Sana Biotechnology annual cash & cash equivalents is currently $133.52 million, with the most recent change of -$43.25 million (-24.47%) on 31 December 2023. During the last 3 years, it has risen by +$8.71 million (+6.98%). SANA annual cash & cash equivalents is now -47.23% below its all-time high of $253.03 million, reached on 31 December 2021.SANA Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$127.00 M
-$7.96 M-5.90%
30 September 2024
Summary:
Sana Biotechnology quarterly cash and cash equivalents is currently $127.00 million, with the most recent change of -$7.96 million (-5.90%) on 30 September 2024. Over the past year, it has dropped by -$41.45 million (-24.61%). SANA quarterly cash and cash equivalents is now -83.08% below its all-time high of $750.69 million, reached on 31 March 2021.SANA Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SANA Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -24.5% | -24.6% |
| 3 y3 years | +7.0% | -70.7% |
| 5 y5 years | +335.9% | - |
SANA Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -47.2% | +7.0% | -70.7% | at low |
| 5 y | 5 years | -47.2% | +335.9% | -83.1% | +58.7% |
| alltime | all time | -47.2% | +335.9% | -83.1% | +58.7% |
Sana Biotechnology Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $127.00 M(-5.9%) |
| June 2024 | - | $134.96 M(-23.8%) |
| Mar 2024 | - | $177.05 M(+32.6%) |
| Dec 2023 | $133.52 M(-24.5%) | $133.52 M(-20.7%) |
| Sept 2023 | - | $168.45 M(-3.1%) |
| June 2023 | - | $173.79 M(+8.3%) |
| Mar 2023 | - | $160.46 M(-9.2%) |
| Dec 2022 | $176.76 M | $176.76 M(+8.2%) |
| Sept 2022 | - | $163.34 M(-16.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2022 | - | $194.66 M(+3.3%) |
| Mar 2022 | - | $188.52 M(-25.5%) |
| Dec 2021 | $253.03 M(+102.7%) | $253.03 M(-41.7%) |
| Sept 2021 | - | $433.67 M(-35.8%) |
| June 2021 | - | $675.14 M(-10.1%) |
| Mar 2021 | - | $750.69 M(+501.5%) |
| Dec 2020 | $124.81 M(+55.9%) | $124.81 M(-16.4%) |
| Sept 2020 | - | $149.22 M(+86.5%) |
| Dec 2019 | $80.03 M(+161.3%) | $80.03 M |
| Dec 2018 | $30.63 M | - |
FAQ
- What is Sana Biotechnology annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Sana Biotechnology?
- What is Sana Biotechnology annual cash & cash equivalents year-on-year change?
- What is Sana Biotechnology quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Sana Biotechnology?
- What is Sana Biotechnology quarterly cash and cash equivalents year-on-year change?
What is Sana Biotechnology annual cash & cash equivalents?
The current annual cash & cash equivalents of SANA is $133.52 M
What is the all time high annual cash & cash equivalents for Sana Biotechnology?
Sana Biotechnology all-time high annual cash & cash equivalents is $253.03 M
What is Sana Biotechnology annual cash & cash equivalents year-on-year change?
Over the past year, SANA annual cash & cash equivalents has changed by -$43.25 M (-24.47%)
What is Sana Biotechnology quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of SANA is $127.00 M
What is the all time high quarterly cash and cash equivalents for Sana Biotechnology?
Sana Biotechnology all-time high quarterly cash and cash equivalents is $750.69 M
What is Sana Biotechnology quarterly cash and cash equivalents year-on-year change?
Over the past year, SANA quarterly cash and cash equivalents has changed by -$41.45 M (-24.61%)